Multimeric Biotherapeutics, Inc.

MegaLigand image

Clinical Advisory Board

 

Gregory A. Daniels, M.D., Ph.D.

Director, Melanoma Program, Moores UCSD Cancer Center

Dr. Daniels is an oncologist interested in immune therapies for cancer. He received his B.A. and M.S. degrees from UCSD, his Ph.D. from Stanford in Cancer Biology, and his M.D. from the University of Southern California. He completed training in Internal Medicine and Medical Oncology at the Mayo Clinic and then moved to UCSD as an Assistant Professor of Medicine in the Division of Medical Oncology. As a basic researcher, Dr. Daniels has used preclinical models to pioneer the development of new immune treatments for cancer, including vaccines containing CD40L and TLR agonists. As a clinical investigator, he has studied the effectiveness of DNA cancer vaccines, immunostimulatory monoclonal antibodies, and interferon in clinical trials for melanoma. For MultimericBio, Dr. Daniels will design and conduct its clinical trial of UltraCD40L for melanoma.

Steven C. Plaxe, M.D., FACOG, FACS

Director, Division of Gynecological Oncology, UCSD

Dr. Plaxe is a specialist in gynecological cancers at the University of California San Diego. He has been consistently voted as one of San Diego's Top Doctors and has received many awards for clinical excellence. He is an Editor of Gynecologic Oncology, Co-Editor of the section on endometrial cancer in the widely consulted on-line reference, UpToDate, and the author of 37 papers on ovarian cancer. He has been a Principal Investigator on eight clinical trials in gynecological cancers, including five studies of the Gynecologic Oncology Group (GOG). Dr. Plaxe received his Bachelor's degree from Yale in Molecular Biophysics and Biochemisty, his M.D. from the Mount Sinai School of Medicine, OB-GYN residency training at Yale-New Haven Hospital, and Gynecological Oncology Fellowship training at the Mount Sinai Hospital in New York. He has been Director of the Division of Gynecological Oncology at UCSD since 1995.